Doctors, FDA Approval, Hormones and Insulin - Clinical Research Informer

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Doctors

FDA Approval

Hormones

Insulin

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

The Pharma Data

AUGUST 17, 2021

approval of pump use for Lilly’s novel insulin is latest development designed to help people with diabetes manage blood sugar levels. Lyumjev, a novel formulation of insulin lispro developed to speed the absorption of insulin into the bloodstream and reduce A1C levels, was approved by the FDA in June 2020.

Insulin

Insulin FDA Approval Doctors Doctor

GLP-1 Agonists for Diabetes: Mounjaro Versus Ozempic

XTalks

NOVEMBER 9, 2022

Since Mounjaro’s May US Food and Drug Administration (FDA) approval, sales of the drug have skyrocketed beyond initial expectations owing to patient demand and a temporary shortage of Novo’s Ozempic. dependent insulin secretion and suppression of glucagon release. And the demand won’t be easing anytime soon. billion by 2030.

Insulin

Insulin Hormones FDA Approval Sales

FDA approves Lyumjev® (insulin lispro-aabc injection) 100 units/mL for use in insulin pumps

GLP-1 Agonists for Diabetes: Mounjaro Versus Ozempic

Stay Connected